United States Biological

Executive Summary

United States Biological (USB) is a privately held, established supplier of life science research reagents, specializing in antibodies, proteins, and biochemicals. Founded in 1985 and headquartered in Salem, Massachusetts, the company has built a reputation for providing high-quality, well-characterized products that support academic, government, and industrial research globally. USB's extensive catalog spans diverse fields such as immunology, neuroscience, cancer research, and cell biology, making it a reliable partner for scientists seeking reproducible experimental results. With over three decades of operational history, USB benefits from deep industry relationships, a loyal customer base, and a broad distribution network. The company's long-term stability and focus on quality position it as a steady, albeit low-profile, player in the competitive reagents market. Despite its conservative growth trajectory, USB continues to invest in product development and quality assurance, ensuring compliance with evolving research standards. While the company operates in a fragmented market with many competitors, its longevity and customer trust provide a competitive moat. USB's potential for growth lies in expanding its catalog with novel reagents, entering adjacent markets, or leveraging partnerships to increase its global footprint. However, as a private entity, financial details are limited, and near-term growth may be modest. The company's resilience and essential role in research infrastructure support a moderate conviction rating.

Upcoming Catalysts (preview)

• TBDLaunch of recombinant antibody catalog70% success
• TBDStrategic partnership with a major research institution40% success
• TBDExpansion into Asia-Pacific distribution channels60% success